Corporate News     09-Nov-23 Piramal Pharma's Bethlehem unit clears USFDA inspection Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR) for the company's manufacturing unit located at Bethlehem, USA and the inspection has now been successfully closed by the USFDA. Previous News   Piramal Pharma gains after successful completion of US FDA inspection at Pithampur facility  ( Hot Pursuit - 22-May-23   10:58 )   Piramal Pharma to hold board meeting  ( Corporate News - 02-Feb-23   14:08 )   Piramal Pharma receives SBTi validation for its GHG commitment  ( Corporate News - 17-Sep-24   10:14 )   Piramal Pharma reports consolidated net loss of Rs 88.64 crore in the June 2024 quarter  ( Results - Announcements 26-Jul-24   14:33 )   Piramal Pharma to discuss results  ( Corporate News - 14-Jan-25   14:25 )   Piramal Pharma Q3 PAT drops 64% YoY to Rs 4 crore  ( Hot Pursuit - 29-Jan-25   11:53 )   Piramal Pharma schedules board meeting  ( Corporate News - 24-May-23   10:52 )   Piramal Pharma's Bethlehem unit clears USFDA inspection  ( Corporate News - 09-Nov-23   14:05 )   Piramal Pharma Q1 net loss narrows to Rs 89 crore  ( Hot Pursuit - 26-Jul-24   14:28 )   Piramal Pharma forays into men's grooming market in India with launch of BOHEM  ( Corporate News - 10-Apr-24   16:54 )   Piramal Pharma to table results  ( Corporate News - 16-Jul-24   10:59 )	Other Stories   Focus Business Solution schedules board meeting   22-Mar-25   17:29   MBL Infrastructure announces board meeting date   22-Mar-25   17:29   Board of Karnika Industries recommends interim dividend   22-Mar-25   17:29   Modern Dairies to convene board meeting   22-Mar-25   17:29   Lucent Industries to convene EGM   22-Mar-25   17:24   Party Cruisers to hold EGM   22-Mar-25   17:24   Fidel Softech to hold EGM   22-Mar-25   17:24   Huhtamaki India schedules AGM   22-Mar-25   17:23   Khandwala Securities to conduct board meeting   22-Mar-25   17:23   Phoenix Overseas to convene board meeting   22-Mar-25   17:23
Back Top